Deargen
Business Services · South Korea · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Dongwon F&b 60 Mabang-ro, Seocho-gu, Seo...Phone Number
+82 427162100Website
www.deargen.meRevenue
<$5 MillionIndustry
About Deargen
Established in December 2016, Deargen (President: Kilsoo Kang) is an AI-based drug discovery and development company. In February 2020, the company released study results on predicting the development of COVID-19 treatments. Candidate compounds for treating COVID-19 predicted by Deargen include remdesivir, which was first approved as an emergency therapy. The company conducts research on and owns core AI technologies in-silico, such as 'prediction of bio-markers', 'selection of disease targets', and 'extraction of candidate substances for new drugs', utilizing techniques of meta analysis of genome big data and its unique AI technologies. Building on these outcomes, the company is developing new drugs in collaboration with multiple pharmaceutical companies and research institutions, demonstrating its outstanding technology capabilities as being named as top awardees at the ILSVRC, a world-prominent deep-learning competition, and Dream Challenge, an international AI-based new drug develoRead more
Deargen Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Deargen Tech Stack
A closer look at the technologies used by Deargen
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Deargen
Sign Up For FreeTo access detailed company insights
Established in December 2016, Deargen (President: Kilsoo Kang) is an AI-based drug discovery and development company. In February 2020, the company released study results on predicting the development of COVID-19 treatments. Candidate compounds for treating COVID-19 predicted by Deargen include remdesivir, which was first approved as an emergency t... Read More
